. Author manuscript; available in PMC: 2019 Jun 14.

Published in final edited form as: J Am Board Fam Med. 2019 May-Jun;32(3):398–407. doi: 10.3122/jabfm.2019.03.180271

Table 3.

Cardiovascular Disease Prevention Clinical Quality Measures by Ownership Type^*

Measure	Observations^†	Physician-Owned Practices	Health System/Medical Group Practices			FQHC Practices
Measure	Observations^†	Value	Value	Difference (95% CI)	P value	Value	Difference (95% CI)	P value

Aspirin (Values showing %)	886	57.5	67.5	10.0 (0.2 to 21.5)	.08	59.1	1.6 (–8.2 to 10.5)	.73
Blood pressure (Values showing %)	892	64.0	60.6	3.4 (–7.3 to 2.0)	.15	64.3	0.3 (–6.4 to 9.2)	.94
Cholesterol (Values showing %)	679	58.2	58.2	0.1 (–8.7 to 14.3)	.99	55.2	3.0 (–7.9 to 4.7)	.38
Smoking (Values showing %)	869	51.0	67.3	16.3 (1.8 to 24.2)	.004	69.3	18.3 (1.1 to 26.7)	.004
Number of practices (Values showing numbers)	989	526		253			210

Based on practice surveys of practices participating in EvidenceNOW, collected between October 2015 and April 2017. See Appendix A for a definition of the four cardiovascular disease prevention clinical quality measures.

^†

The column “Observations” shows the number of practices with an observed value for the respective measure.

CI, confidential interval; FQHC, federally qualified health center.